The PE Ratio as of November 2024 (TTM) for HUTCHMED (China) Limited (HCM) is -69.44

According to HUTCHMED (China) Limited’s latest financial reports and current stock price. The company's current PE Ratio is -69.44. This represents a change of -178.97% compared to the average of 87.94 of the last 4 quarters.

HUTCHMED (China) Limited (HCM) Historical PE Ratio (quarterly & annually)

How has HCM PE Ratio performed in the past?

The mean historical PE Ratio of HUTCHMED (China) Limited over the last ten years is 142.92. The current -69.44 PE Ratio has changed -4958.69% with respect to the historical average. Over the past ten years (40 quarters), HCM's PE Ratio was at its highest in in the March 2016 quarter at 7.24K. The PE Ratio was at its lowest in in the March 2018 quarter at -419.93.

HUTCHMED (China) Limited (HCM) PE Ratio by Quarter and Year

Discovering the peaks and valleys of HUTCHMED (China) Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

HUTCHMED (China) Limited (HCM) Average PE Ratio

How has HCM PE Ratio performed in the past?

The current PE Ratio of HUTCHMED (China) Limited (HCM) is less than than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

HUTCHMED (China) Limited (HCM) PE Ratio vs. Peers

How is HCM’s PE Ratio compared to its peers?

HUTCHMED (China) Limited’s PE Ratio is less than Eagle Pharmaceuticals, Inc. (0.34), greater than ANI Pharmaceuticals, Inc. (-155.73), less than Phibro Animal Health Corporation (55.24), less than Deciphera Pharmaceuticals, Inc. (-11.74), less than Prestige Consumer Healthcare Inc. (20.46), less than Pacira BioSciences, Inc. (-8.92), less than Collegium Pharmaceutical, Inc. (10.91), less than Procaps Group S.A. (2.68), less than Silver Spike Investment Corp. (13.39), less than Alkermes plc (14.10), greater than Intra-Cellular Therapies, Inc. (-104.94), less than Ironwood Pharmaceuticals, Inc. (21.99), less than Regencell Bioscience Holdings Limited (-15.65),

Build a custom stock screener for HUTCHMED (China) Limited (HCM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like HUTCHMED (China) Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

HUTCHMED (China) Limited (HCM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like HUTCHMED (China) Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.